La Jolla Pharmaceutical (LJPC) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	100.56M
Prepaids and other current assets	1.36M
Total current assets	102.3M
Total assets	104.77M
Accounts payable	2.26M
Accrued expenses	2.11M
Accrued payroll and related expenses	795K
Derivative liabilities
Total current liabilities	5.16M
Series C-1 redeemable convertible preferred stock, $0.0001 par value; 11,000 shares authorized, 5,325 and 5,573 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively (redemption value and liquidation preference in the aggregate of $5,325 at June 30, 2011 and $5,652 at December 31, 2010) (see Notes 1 and 5)
Commitments and contingencies
Common stock	2K
Additional paid-in capital	653.54M
Accumulated deficit	-560.57M
Total stockholders' (deficit) equity	99.61M
Total liabilities, redeemable convertible preferred stock and stockholders' (deficit) equity	104.77M

Entities mentioned with LJPC

View All Entities